Healthcare merger and acquisition (M&A) activity in the fourth quarter of 2020 exceeded $8.3 billion in disclosed transaction value across 524 deals in Canada and the US. The average deal size among disclosed transactions was$15.9 million, a slight decline from $18.2 million in the third quarter of 2020. In Canada, the top Healthcare sub-sectors for deal activity in the quarter were pharmaceuticals (16), healthcare technology (13), healthcare services (11)and drug retail (9). Together, these sub-sectors accounted for over 77% of Canadian Healthcare deal volume. In2020, industry EV/EBITDA multiples (based on private equity transactions listed below) increased 27% from the previous year and averaged a multiple of 7.1x for lower mid-market transaction values (10 – 25 million range).
Insights
-
Confidence
October 07, 2025
What key trends are emerging in Canadian debt and capital markets? Gain insights into the current state, emerging trends, and strategic outlook in MNP’s Q3 2025 report.
-
Agility
October 07, 2025
Technology is getting faster and smarter. And it begs the question: where do humans have the edge?
-
October 01, 2025
Quantum computing threatens today’s encryption. Discover what post-quantum encryption is, why it matters now, and how organizations can prepare.
